Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
09/2001
09/06/2001US20010020021 Metalloprotease inhibitor
09/06/2001US20010019993 From alkylene oxide and carbon dioxide using organometallic catalyst
09/05/2001EP1129120A1 Modified isocyanates
09/05/2001CN1311676A Compound that inhibit the binding of integrins to their receptors
09/04/2001US6284901 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same
08/2001
08/30/2001WO2001062744A2 Substituted piperazine compounds
08/30/2001WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
08/30/2001WO2001062711A2 Substituted alkylene diamine compounds
08/30/2001US20010018544 Reacting a polyene diacetal with a cyclic dienol ether in presence of Lewis acid
08/30/2001US20010018525 Modulating blood glucose concentration
08/30/2001US20010018205 Process for stereospecific hydrolysis of piperidinedione derivatives
08/30/2001CA2657986A1 Substituted piperazine compounds
08/30/2001CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
08/29/2001EP1127060A1 Hydroboronation process
08/29/2001EP1127056A1 Method for producing monohalogenated 2-oxo-1,3-dioxolanes
08/29/2001EP1127043A1 Stereoselective process for preparing (cyclo)alkyl phenylglycolic acids
08/29/2001EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
08/29/2001EP0810868B1 Use of piperine as a gastrointestinal absorption enhancer
08/29/2001EP0738260B1 Pesticides
08/29/2001CN1310709A N.N-substituted cyclic amine derivatives
08/29/2001CN1310180A New compound
08/29/2001CN1310171A New tricyclic derivate and their producing process
08/29/2001CN1070173C Benzoylaguanidine derivatives using as medicine
08/28/2001US6281211 Treating a disorder responsive to the blockade of sodium channels
08/28/2001CA2054706C Very large scale immobilized polymer synthesis
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/23/2001WO2001060803A1 Fused imidazolium derivatives
08/23/2001WO2001060781A2 Diphenyl compounds, formulations and uses thereof
08/23/2001WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives
08/23/2001WO2000071520A3 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
08/23/2001US20010016664 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application
08/22/2001EP1125908A1 New phenolic compounds derived from dialkoxyethanals, their preparation process and their application
08/22/2001EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
08/22/2001CN1309631A Aminomethylcarboxylic acid derivs
08/21/2001US6278026 Intermediates for tricyclic or tetracyclic taxanes
08/21/2001US6277876 Antiinflammatory agents; prevent tissue degradation
08/21/2001US6277867 Synergistic mixtures
08/16/2001WO2001058894A1 Stereoselective synthesis of nucleoside analogues
08/16/2001WO2001058853A1 Dehydroamino acids
08/16/2001WO2000047551A3 Inhibitors of aspartyl protease
08/16/2001US20010014694 Hypotensive agents, stroke, vision defects, kidney disorders
08/16/2001EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation
08/16/2001EP0558677B1 Biologically active amines
08/16/2001CA2397993A1 Dehydroamino acids
08/15/2001CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
08/15/2001CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
08/14/2001US6274737 Endothelin receptor antagonists
08/14/2001US6274600 Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by AMPA receptors
08/09/2001WO2001057016A1 Process for preparing piperonal
08/09/2001WO2001056563A1 Adamantyl derivatives as anti-cancer agents
08/09/2001WO2001056538A1 Novel coupler for use in oxidative hair dyeing
08/09/2001WO2001010834A9 Antibacterial agents
08/09/2001US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
08/08/2001EP1121351A2 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
08/07/2001US6271399 Methyl 3-(3,4-methylenedioxyphenyl)-6-(prop-1-yloxy)-indane-2-carboxylate derivatives
08/07/2001US6271253 Cyclooxygenase inhibitors
08/02/2001WO2001055109A1 Aromatic amides acting on melanocortin receptors
08/02/2001WO2001055085A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity
08/02/2001WO2000076971A3 Serine protease inhibitors
08/02/2001WO2000066175A3 Conjugates as therapies for cancer and prostate diseases
08/02/2001CA2395298A1 Propionic acid derivatives and their use in the treatment of diabetes and obesity
08/01/2001EP1119561A1 Process for the preparation of alkylene carbonate
08/01/2001EP1119550A1 2-substituted heterocyclic sulfonamides
08/01/2001EP1119542A1 Prostaglandin receptor ligands
08/01/2001CN1306526A Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
08/01/2001CN1306422A Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for treatment or prevention of diseases characterized by abnormal cell proliferation
07/2001
07/31/2001US6268520 Used forpreparation of optically active or racemic colchicine and thiocolchicine derivatives
07/31/2001US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis.
07/31/2001US6268313 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
07/26/2001WO1999015129A3 SELECTIVE cPLA2 INHIBITORS
07/25/2001EP1117636A1 Method for preparing trion-bis(oxime ether) derivatives andrion-mono and trion-bis(oxime ether) derivatives obtained therewith
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001EP1084099A4 Process for the preparation of protected 3-amino-1,2-dihydroxypropane acetal and derivatives thereof
07/25/2001EP0888328B1 Chiral compounds and their use as doping agents in liquid crystals
07/25/2001EP0854861B1 Oxyamino oxime ethers, methods and intermediate products for their production, and agents containing them and used for controlling harmful fungi and pests
07/25/2001CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein
07/25/2001CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase
07/25/2001CN1305453A Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same
07/25/2001CN1305124A Photo sensitive resin composition
07/25/2001CN1304935A Preparation method of vinylene carbonate and its application
07/25/2001CN1068865C Ethylene glycol preparation process
07/24/2001US6265612 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
07/24/2001US6265592 Reacting oxirane compound with carbon dioxide in the liquid phase in presence of catalyst for continuous production of 1,3-dioxolan-2-ones
07/24/2001US6265428 Vasodilation
07/24/2001US6265209 Subjecting racemic compound to transesterification with acylating agent in presence of hydrolase to optically resolve compound into optically active diester, then alcoholysis
07/19/2001WO2001052340A1 New electrolytes and lithium ion battery using the same
07/19/2001WO2001051456A2 Antibacterial agents
07/19/2001WO2001044172A8 Salicylamides as serine protease and factor xa inhibitors
07/19/2001WO2000076970A3 Serine protease inhibitors
07/19/2001DE19955944A1 Verfahren zur Herstellung von Vinylencarbonat und dessen Verwendung Process for the preparation of vinylene carbonate and its use
07/19/2001CA2397575A1 Antibacterial agents
07/18/2001EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds
07/18/2001EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
07/18/2001EP1115700A1 Optically active substituted n-aryl-o-aryloxyalkyl-carbamates
07/18/2001EP0939749B1 Process for the preparation of benzyl-ethers
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001CN1303848A Method for synthesizing beta-biphenyl diester
07/17/2001US6262278 Reacting water and mixture of stereoisomers of chiral cyclic substrate in the presence of non-racemic chiral catalyst to produce by kinetic resolution stereoisomerically enriched cyclic substrate or stereoisomerically enriched hydrolyzate
07/17/2001US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase
07/17/2001US6262084 Compounds that inhibit the binding of integrins to their receptors